Imagin Medical Inc
CNSX:IME
Operating Margin
Imagin Medical Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
CA |
I
|
Imagin Medical Inc
CNSX:IME
|
162.5k CAD | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
224.1B USD |
18%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.9B USD |
29%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
156.8B USD |
19%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
153.3B USD |
22%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
116.8B USD |
20%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.2B EUR |
14%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
52.2B USD |
13%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD |
28%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.3B USD |
29%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.6B USD |
32%
|
Imagin Medical Inc
Glance View
Imagin Medical, Inc. engages in the development and provision of medical imaging products. The company is headquartered in Vancouver, British Columbia. The firm is engaged in the research, development and commercialization of medical devices in the bio-chemistry industry The Company’s product, the i/Blue Imaging System, with its optics and light sensors that is focused on detecting cancer for removal and helping to reduce recurrence rates.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Imagin Medical Inc's most recent financial statements, the company has Operating Margin of 0%.